Incorporating cMyBP-C and hs-cTnT – effectively rules out AMI, showing non-inferiority to hs-cTnT-only-based rapid rule-out algorithms and offers a promising alternative, potentially enhancing clinical decision-making in emergency settings.
Patented biomarker for cardiac injury.
Patented biomarker for cardiac injury.
Imprint: KDx Acceleration, 38 rue de Berri, 75008 Paris, France
© Copyright 2021-2025 KDx Acceleration. All rights reserved.
© Copyright 2021-2025 KDx Acceleration. All rights reserved.